Literature DB >> 1446715

Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain.

B J Chiasson1, M L Hooper, P R Murphy, H A Robertson.   

Abstract

Immediate-early genes such as c-fos and NGFI-A are rapidly and transiently expressed in the striatum following amphetamine administration in vivo. Here we show that direct infusion of an antisense oligodeoxynucleotide to c-fos into striatum will reduce amphetamine-induced production of Fos-like immunoreactivity without affecting NGFI-A expression. These results suggest that it is possible to use antisense technology to study the role of immediate-early genes in specific sites in the brain in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446715     DOI: 10.1016/0922-4106(92)90167-t

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  16 in total

Review 1.  Designing antisense to inhibit the renin-angiotensin system.

Authors:  D Mohuczy; M I Phillips
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  MR contrast probes that trace gene transcripts for cerebral ischemia in live animals.

Authors:  Christina H Liu; Shuning Huang; Jiankun Cui; Young R Kim; Christian T Farrar; Michael A Moskowitz; Bruce R Rosen; Philip K Liu
Journal:  FASEB J       Date:  2007-05-03       Impact factor: 5.191

Review 3.  Application of antisense DNA method for the study of molecular bases of brain function and behavior.

Authors:  S Ogawa; D W Pfaff
Journal:  Behav Genet       Date:  1996-05       Impact factor: 2.805

4.  c-fos expression in the amygdala: in vivo antisense modulation and role in anxiety.

Authors:  C Möller; O Bing; M Heilig
Journal:  Cell Mol Neurobiol       Date:  1994-10       Impact factor: 5.046

Review 5.  Design and application of antisense oligonucleotides in cell culture, in vivo, and as therapeutic agents.

Authors:  W Brysch; K H Schlingensiepen
Journal:  Cell Mol Neurobiol       Date:  1994-10       Impact factor: 5.046

Review 6.  The potential role of antisense oligodeoxynucleotide therapy for cardiovascular disease.

Authors:  M I Phillips; S M Galli; J L Mehta
Journal:  Drugs       Date:  2000-08       Impact factor: 9.546

7.  Suppression of postischemic hippocampal nerve growth factor expression by a c-fos antisense oligodeoxynucleotide.

Authors:  J K Cui; C Y Hsu; P K Liu
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

8.  Suppression of ischemia-induced fos expression and AP-1 activity by an antisense oligodeoxynucleotide to c-fos mRNA.

Authors:  P K Liu; A Salminen; Y Y He; M H Jiang; J J Xue; J S Liu; C Y Hsu
Journal:  Ann Neurol       Date:  1994-10       Impact factor: 10.422

9.  Forebrain ischemia-reperfusion simulating cardiac arrest in mice induces edema and DNA fragmentation in the brain.

Authors:  Christina H Liu; Shuning Huang; Young R Kim; Bruce R Rosen; Philip K Liu
Journal:  Mol Imaging       Date:  2007 May-Jun       Impact factor: 4.488

10.  Cell and tissue distribution of synthetic oligonucleotides in healthy and tumor-bearing nude mice. An autoradiographic, immunohistological, and direct fluorescence microscopy study.

Authors:  F Plenat; N Klein-Monhoven; B Marie; J M Vignaud; A Duprez
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.